BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 297 filers reported holding BIONTECH SE in Q2 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $109,357,784 | +32.8% | 1,006,607 | +31.9% | 0.02% | +35.3% |
| Q2 2023 | $82,376,277 | -2.1% | 763,238 | +12.9% | 0.02% | -10.5% |
| Q1 2023 | $84,178,800 | -59.1% | 675,755 | -50.7% | 0.02% | -63.5% |
| Q4 2022 | $205,983,767 | +15.0% | 1,371,214 | +3.3% | 0.05% | +13.0% |
| Q3 2022 | $179,046,000 | -43.0% | 1,327,448 | -37.0% | 0.05% | -41.0% |
| Q2 2022 | $314,065,000 | -27.7% | 2,106,405 | -17.3% | 0.08% | +2.6% |
| Q1 2022 | $434,223,000 | -79.0% | 2,545,868 | -68.3% | 0.08% | +22.6% |
| Q4 2021 | $2,067,238,000 | +39.4% | 8,018,766 | +47.6% | 0.06% | -68.8% |
| Q3 2021 | $1,483,357,000 | +87.6% | 5,433,741 | +53.8% | 0.20% | +77.7% |
| Q2 2021 | $790,872,000 | +166.7% | 3,532,571 | +30.1% | 0.11% | +143.5% |
| Q1 2021 | $296,491,000 | -2.4% | 2,715,371 | -27.2% | 0.05% | +84.0% |
| Q4 2020 | $303,912,000 | +93.2% | 3,728,088 | +64.0% | 0.02% | -16.7% |
| Q3 2020 | $157,343,000 | +373.3% | 2,272,752 | +356.3% | 0.03% | +328.6% |
| Q2 2020 | $33,241,000 | – | 498,068 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |